Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 37 (GPR37) is a Class A GPCR primarily expressed in the central nervous system, particularly in neurons and glia. It functions in oligodendrocyte differentiation, CNS myelination, and neuroprotection through interactions with prosaposin and osteocalcin. GPR37 primarily couples to Gi/o proteins, inhibiting cAMP production and activating MAPK/ERK pathways. It has been implicated in Parkinson’s disease, cancer, stroke and multiple sclerosis. The long N-terminal domain undergoes rapid metalloprotease-mediated cleavage; the cleaved ectodomain is shed into the extracellular space.
Gi/o protein activation, inhibition of adenylyl cyclase, activation of MAPK/ERK pathway, β-arrestin recruitment
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 37 (GPR37).